HALOZYME THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
  • Halozyme Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 130M shares, a 2.95% decline year-over-year.
  • Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 134M shares, a 4.56% decline from 2022.
  • Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 141M shares, a 4.22% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 147M shares, a 3.77% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 130M -3.95M -2.95% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 129M -4.32M -3.24% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 129M -9.01M -6.54% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 134M -6.41M -4.56% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 134M -5.3M -3.81% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 134M -8.67M -6.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 138M -3.38M -2.39% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 141M -6.19M -4.22% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 139M -7.3M -4.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 142M -5.41M -3.66% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 141M -7.26M -4.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 147M +1.67M +1.15% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 147M +4.61M +3.24% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 148M +9.54M +6.91% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 149M +11.4M +8.28% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 145M +4.08M +2.89% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-23
Q3 2020 142M -4.06M -2.78% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 138M -7.33M -5.04% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 137M -10.3M -6.98% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 141M -3.16M -2.19% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 146M +2.19M +1.52% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 145M +1.84M +1.28% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 147M +4.82M +3.38% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2018 144M -1.43M -0.98% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 144M +713K +0.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 144M +9.56M +7.13% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 143M +14M +10.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 146M +16.4M +12.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 143M +15.1M +11.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-21
Q2 2017 134M -494K -0.37% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-21
Q1 2017 129M +3.32M +2.65% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-21
Q4 2016 129M 0 0% Oct 1, 2016 Dec 31, 2016 10-K 2017-02-28
Q3 2016 128M +1.23M +0.97% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 135M 0 0% Apr 1, 2016 Jun 30, 2016 10-K 2017-02-28
Q1 2016 125M 0 0% Jan 1, 2016 Mar 31, 2016 10-K 2017-02-28
Q4 2015 129M Oct 1, 2015 Dec 31, 2015 10-K 2016-02-29
Q3 2015 127M Jul 1, 2015 Sep 30, 2015 10-K 2016-02-29
Q2 2015 135M +10.8M +8.73% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 125M Jan 1, 2015 Mar 31, 2015 10-K 2016-02-29
Q2 2014 124M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q3 2012 112M +7.3M +6.95% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 112M +7.67M +7.35% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-09
Q4 2011 103M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 105M +11.4M +12.2% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 104M +12.6M +13.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 101M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q3 2010 93.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 91.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.